Cencora, Inc. (COR)
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.
Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High
Cencora hit an all-time high on Friday. The post Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High appeared first on Investor's Business Daily.
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.
Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year?
Here is how Cencora (COR) and Intensity Therapeutics Inc. (INTS) have performed compared to their sector so far this year.
Cencora (COR) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Medical Services Industry Stocks to Buy as AI Fuels Growth
The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most.
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here is Why Growth Investors Should Buy Cencora (COR) Now
Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NVDA, COR, JBL and KLAC hold promise.
Here's Why You Should Add Cencora Stock to Your Portfolio Now
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Why Is Cencora (COR) Up 3.1% Since Last Earnings Report?
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
